Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 279

1.

Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening.

Munck A, Bourmaud A, Bellon G, Picq P, Farrell PM; DPAM Study Group.

Pediatr Pulmonol. 2020 Jan 9. doi: 10.1002/ppul.24634. [Epub ahead of print]

PMID:
31916691
2.

The future of cystic fibrosis care: a global perspective.

Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, Burgel PR, Tullis E, Castaños C, Castellani C, Byrnes CA, Cathcart F, Chotirmall SH, Cosgriff R, Eichler I, Fajac I, Goss CH, Drevinek P, Farrell PM, Gravelle AM, Havermans T, Mayer-Hamblett N, Kashirskaya N, Kerem E, Mathew JL, McKone EF, Naehrlich L, Nasr SZ, Oates GR, O'Neill C, Pypops U, Raraigh KS, Rowe SM, Southern KW, Sivam S, Stephenson AL, Zampoli M, Ratjen F.

Lancet Respir Med. 2020 Jan;8(1):65-124. doi: 10.1016/S2213-2600(19)30337-6. Epub 2019 Sep 27. Review. Erratum in: Lancet Respir Med. 2019 Dec;7(12):e40.

PMID:
31570318
3.

Spin Lock Adiabatic Correction (SLAC) for B1-insensitive pulse design at 7T.

Green EM, Blunck Y, Tahayori B, Farrell PM, Korte JC, Johnston LA.

J Magn Reson. 2019 Nov;308:106595. doi: 10.1016/j.jmr.2019.106595. Epub 2019 Sep 11.

PMID:
31542447
4.

Inconclusive diagnosis after a positive newborn bloodspot screening result for cystic fibrosis; clarification of the harmonised international definition.

Southern KW, Barben J, Gartner S, Munck A, Castellani C, Mayell SJ, Davies JC, Winters V, Murphy J, Salinas D, McColley SA, Ren CL, Farrell PM.

J Cyst Fibros. 2019 Nov;18(6):778-780. doi: 10.1016/j.jcf.2019.04.010. Epub 2019 Apr 24. No abstract available.

PMID:
31027826
5.

Identification of molecular signatures of cystic fibrosis disease status with plasma-based functional genomics.

Levy H, Jia S, Pan A, Zhang X, Kaldunski M, Nugent ML, Reske M, Feliciano RA, Quintero D, Renda MM, Woods KJ, Murkowski K, Johnson K, Verbsky J, Dasu T, Ideozu JE, McColley S, Quasney MW, Dahmer MK, Avner E, Farrell PM, Cannon CL, Jacob H, Simpson PM, Hessner MJ.

Physiol Genomics. 2019 Jan 1;51(1):27-41. doi: 10.1152/physiolgenomics.00109.2018. Epub 2018 Dec 12.

6.

Early life growth patterns persist for 12 years and impact pulmonary outcomes in cystic fibrosis.

Sanders DB, Zhang Z, Farrell PM, Lai HJ; Wisconsin CF Neonatal Screening Group.

J Cyst Fibros. 2018 Jul;17(4):528-535. doi: 10.1016/j.jcf.2018.01.006. Epub 2018 Feb 1.

7.

Poor recovery from cystic fibrosis pulmonary exacerbations is associated with poor long-term outcomes.

Sanders DB, Zhao Q, Li Z, Farrell PM.

Pediatr Pulmonol. 2017 Oct;52(10):1268-1275. doi: 10.1002/ppul.23765. Epub 2017 Sep 7.

8.

Poor recovery from a pulmonary exacerbation does not lead to accelerated FEV1 decline.

Sanders DB, Li Z, Zhao Q, Farrell PM.

J Cyst Fibros. 2017 Jul 29. pii: S1569-1993(17)30818-4. doi: 10.1016/j.jcf.2017.07.003. [Epub ahead of print]

9.

The Evolution of the Medical School Deanship: From Patriarch to CEO to System Dean.

Schieffler DA, Farrell PM, Kahn MJ, Culbertson RA.

Perm J. 2017;21:16-069. doi: 10.7812/TPP/16-069.

10.

Diagnosis of Cystic Fibrosis in Nonscreened Populations.

Sosnay PR, White TB, Farrell PM, Ren CL, Derichs N, Howenstine MS, Nick JA, De Boeck K.

J Pediatr. 2017 Feb;181S:S52-S57.e2. doi: 10.1016/j.jpeds.2016.09.068.

PMID:
28129813
11.

Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation.

Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, Howenstine M, McColley SA, Rock M, Rosenfeld M, Sermet-Gaudelus I, Southern KW, Marshall BC, Sosnay PR.

J Pediatr. 2017 Feb;181S:S4-S15.e1. doi: 10.1016/j.jpeds.2016.09.064. Erratum in: J Pediatr. 2017 May;184:243.

12.

Diagnosis of Cystic Fibrosis in Screened Populations.

Farrell PM, White TB, Howenstine MS, Munck A, Parad RB, Rosenfeld M, Sommerburg O, Accurso FJ, Davies JC, Rock MJ, Sanders DB, Wilschanski M, Sermet-Gaudelus I, Blau H, Gartner S, McColley SA.

J Pediatr. 2017 Feb;181S:S33-S44.e2. doi: 10.1016/j.jpeds.2016.09.065.

13.

Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses.

Sosnay PR, Salinas DB, White TB, Ren CL, Farrell PM, Raraigh KS, Girodon E, Castellani C.

J Pediatr. 2017 Feb;181S:S27-S32.e1. doi: 10.1016/j.jpeds.2016.09.063.

PMID:
28129809
14.

Cystic Fibrosis Diagnostic Challenges over 4 Decades: Historical Perspectives and Lessons Learned.

Farrell PM, White TB, Derichs N, Castellani C, Rosenstein BJ.

J Pediatr. 2017 Feb;181S:S16-S26. doi: 10.1016/j.jpeds.2016.09.067.

PMID:
28129808
15.

Introduction to "Cystic Fibrosis Foundation Consensus Guidelines for Diagnosis of Cystic Fibrosis".

Farrell PM, White TB.

J Pediatr. 2017 Feb;181S:S1-S3. doi: 10.1016/j.jpeds.2016.09.062. No abstract available. Erratum in: J Pediatr. 2017 May;184:243.

PMID:
28129807
16.

Innovative assessment of inpatient and pulmonary drug costs for children with cystic fibrosis.

Levy JF, Rosenberg MA, Farrell PM.

Pediatr Pulmonol. 2016 Dec;51(12):1295-1303. doi: 10.1002/ppul.23554. Epub 2016 Oct 14.

PMID:
27740724
17.

Pubertal Height Growth and Adult Height in Cystic Fibrosis After Newborn Screening.

Zhang Z, Lindstrom MJ, Farrell PM, Lai HJ; Wisconsin Cystic Fibrosis Neonatal Screening Group.

Pediatrics. 2016 May;137(5). pii: e20152907. doi: 10.1542/peds.2015-2907. Epub 2016 Apr 5.

18.

Toward quality improvement in cystic fibrosis newborn screening: Progress and continuing challenges.

Farrell PM, Sommerburg O.

J Cyst Fibros. 2016 May;15(3):267-9. doi: 10.1016/j.jcf.2016.04.008. Epub 2016 May 10. No abstract available.

19.

Refining the continuum of CFTR-associated disorders in the era of newborn screening.

Levy H, Nugent M, Schneck K, Stachiw-Hietpas D, Laxova A, Lakser O, Rock M, Dahmer MK, Biller J, Nasr SZ, Baker M, McColley SA, Simpson P, Farrell PM.

Clin Genet. 2016 May;89(5):539-49. doi: 10.1111/cge.12711. Epub 2016 Jan 20.

20.

Improving the time efficiency of the Fourier synthesis method for slice selection in magnetic resonance imaging.

Tahayori B, Khaneja N, Johnston LA, Farrell PM, Mareels IM.

Phys Med. 2016 Jan;32(1):94-103. doi: 10.1016/j.ejmp.2015.10.088. Epub 2015 Oct 24.

PMID:
26602859
21.

Changing incidence of cystic fibrosis in Wisconsin, USA.

Parker-McGill K, Nugent M, Bersie R, Hoffman G, Rock M, Baker M, Farrell PM, Simpson P, Levy H.

Pediatr Pulmonol. 2015 Nov;50(11):1065-1072. doi: 10.1002/ppul.23265. Epub 2015 Aug 10.

22.

New challenges in the diagnosis and management of cystic fibrosis.

Levy H, Farrell PM.

J Pediatr. 2015 Jun;166(6):1337-41. doi: 10.1016/j.jpeds.2015.03.042. No abstract available.

23.

Solving the Bloch equation with periodic excitation using harmonic balancing: application to Rabi modulated excitation.

Tahayori B, Johnston LA, Layton KJ, Farrell PM, Mareels IM.

IEEE Trans Med Imaging. 2015 Oct;34(10):2118-30. doi: 10.1109/TMI.2015.2423313. Epub 2015 Apr 15.

PMID:
25879910
24.

Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study.

Baker MW, Atkins AE, Cordovado SK, Hendrix M, Earley MC, Farrell PM.

Genet Med. 2016 Mar;18(3):231-8. doi: 10.1038/gim.2014.209. Epub 2015 Feb 12.

25.

Cystic fibrosis newborn screening: a model for neuromuscular disease screening?

Scully MA, Farrell PM, Ciafaloni E, Griggs RC, Kwon JM.

Ann Neurol. 2015 Feb;77(2):189-97. doi: 10.1002/ana.24316. Epub 2014 Dec 13. Review.

PMID:
25425541
26.

Improving the quality of physician communication with rapid-throughput analysis and report cards.

Farrell MH, Christopher SA, La Pean Kirschner A, Roedl SJ, O'Tool FO, Ahmad NY, Farrell PM.

Patient Educ Couns. 2014 Nov;97(2):248-55. doi: 10.1016/j.pec.2014.07.028. Epub 2014 Aug 28.

27.

Dielectric properties of liquid phase molecular clusters using the external field method: molecular dynamics study.

Abeyrathne CD, Halgamuge MN, Farrell PM, Skafidas E.

Phys Chem Chem Phys. 2014 Jul 21;16(27):13943-7. doi: 10.1039/c4cp00716f. Epub 2014 Jun 5.

PMID:
24899067
28.

Rabi resonance in spin systems: theory and experiment.

Layton KJ, Tahayori B, Mareels IM, Farrell PM, Johnston LA.

J Magn Reson. 2014 May;242:136-42. doi: 10.1016/j.jmr.2014.02.014. Epub 2014 Mar 1.

PMID:
24650726
29.

Risk factors for the progression of cystic fibrosis lung disease throughout childhood.

Sanders DB, Li Z, Laxova A, Rock MJ, Levy H, Collins J, Ferec C, Farrell PM.

Ann Am Thorac Soc. 2014 Jan;11(1):63-72. doi: 10.1513/AnnalsATS.201309-303OC.

30.

Long-term follow-up of cystic fibrosis newborn screening: psychosocial functioning of adolescents and young adults.

Tluczek A, Laxova A, Grieve A, Heun A, Brown RL, Rock MJ, Gershan WM, Farrell PM.

J Cyst Fibros. 2014 Mar;13(2):227-34. doi: 10.1016/j.jcf.2013.10.001. Epub 2013 Oct 21.

31.

Association of lung function, chest radiographs and clinical features in infants with cystic fibrosis.

Rosenfeld M, Farrell PM, Kloster M, Swanson JO, Vu T, Brumback L, Acton JD, Castile RG, Colin AA, Conrad CK, Hart MA, Kerby GS, Hiatt PW, Mogayzel PJ, Johnson RC, Davis SD.

Eur Respir J. 2013 Dec;42(6):1545-52. doi: 10.1183/09031936.00138412. Epub 2013 May 30.

32.

Health-related quality of life in children and adolescents with cystic fibrosis: convergent validity with parent-reports and objective measures of pulmonary health.

Tluczek A, Becker T, Grieve A, Laxova A, Rock MJ, Gershan WM, Green CG, Farrell PM.

J Dev Behav Pediatr. 2013 May;34(4):252-61. doi: 10.1097/DBP.0b013e3182905646.

33.

An ab-initio computational method to determine dielectric properties of biological materials.

Abeyrathne CD, Halgamuge MN, Farrell PM, Skafidas E.

Sci Rep. 2013;3:1796. doi: 10.1038/srep01796.

34.

Modelling and estimation of multicomponent T(2) distributions.

Layton KJ, Morelande M, Wright D, Farrell PM, Moran B, Johnston LA.

IEEE Trans Med Imaging. 2013 Aug;32(8):1423-34. doi: 10.1109/TMI.2013.2257830. Epub 2013 Apr 25.

PMID:
23629849
35.

Wisconsin's Lifecourse Initiative for Healthy Families: application of the maternal and child health life course perspective through a regional funding initiative.

Frey CA, Farrell PM, Cotton QD, Lathen LS, Marks K.

Matern Child Health J. 2014 Feb;18(2):413-22. doi: 10.1007/s10995-013-1271-4.

PMID:
23595565
36.

Nutritional status is associated with health-related quality of life in children with cystic fibrosis aged 9-19 years.

Shoff SM, Tluczek A, Laxova A, Farrell PM, Lai HJ.

J Cyst Fibros. 2013 Dec;12(6):746-53. doi: 10.1016/j.jcf.2013.01.006. Epub 2013 Feb 12.

37.

Effects of immediate telephone follow-up with providers on sweat chloride test timing after cystic fibrosis newborn screening identifies a single mutation.

La Pean A, Farrell MH, Eskra KL, Farrell PM.

J Pediatr. 2013 Mar;162(3):522-9. doi: 10.1016/j.jpeds.2012.08.055. Epub 2012 Oct 24.

38.

Immunoreactive Trypsinogen (IRT) as a Biomarker for Cystic Fibrosis: challenges in newborn dried blood spot screening.

Therrell BL Jr, Hannon WH, Hoffman G, Ojodu J, Farrell PM.

Mol Genet Metab. 2012 May;106(1):1-6. doi: 10.1016/j.ymgme.2012.02.013. Epub 2012 Feb 28.

PMID:
22425451
39.

A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis.

Wells J, Rosenberg M, Hoffman G, Anstead M, Farrell PM.

Pediatrics. 2012 Feb;129(2):e339-47. doi: 10.1542/peds.2011-0096. Epub 2012 Jan 30.

40.

Adapting magnetic resonance imaging performance using nonlinear encoding fields.

Layton KJ, Morelande M, Farrell PM, Moran B, Johnston LA.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:3740-3. doi: 10.1109/IEMBS.2011.6090637.

PMID:
22255153
41.

Transformative mutation specific pharmacotherapy for cystic fibrosis.

Sanders DB, Farrell PM.

BMJ. 2012 Jan 9;344:e79. doi: 10.1136/bmj.e79. No abstract available.

PMID:
22232540
42.

The sensitivity of lung disease surrogates in detecting chest CT abnormalities in children with cystic fibrosis.

Sanders DB, Li Z, Rock MJ, Brody AS, Farrell PM.

Pediatr Pulmonol. 2012 Jun;47(6):567-73. doi: 10.1002/ppul.21621. Epub 2011 Dec 13.

43.

Improving communication between doctors and parents after newborn screening.

Farrell MH, Christopher SA, Tluczek A, Kennedy-Parker K, La Pean A, Eskra K, Collins J, Hoffman G, Panepinto J, Farrell PM.

WMJ. 2011 Oct;110(5):221-7.

44.

Regional differences in the evolution of lung disease in children with cystic fibrosis.

Li Z, Sanders DB, Rock MJ, Kosorok MR, Collins J, Green CG, Brody AS, Farrell PM.

Pediatr Pulmonol. 2012 Jul;47(7):635-40. doi: 10.1002/ppul.21604. Epub 2011 Dec 7.

45.

CFTR mutation analysis and haplotype associations in CF patients.

Cordovado SK, Hendrix M, Greene CN, Mochal S, Earley MC, Farrell PM, Kharrazi M, Hannon WH, Mueller PW.

Mol Genet Metab. 2012 Feb;105(2):249-54. doi: 10.1016/j.ymgme.2011.10.013. Epub 2011 Oct 26.

46.

Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies.

Sanders DB, Lai HJ, Rock MJ, Farrell PM.

J Cyst Fibros. 2012 Mar;11(2):150-3. doi: 10.1016/j.jcf.2011.10.002. Epub 2011 Nov 21.

47.

Factors accounting for a missed diagnosis of cystic fibrosis after newborn screening.

Rock MJ, Levy H, Zaleski C, Farrell PM.

Pediatr Pulmonol. 2011 Dec;46(12):1166-74. doi: 10.1002/ppul.21509. Epub 2011 Aug 24.

48.

Associations between academic achievement and psychosocial variables in adolescents with cystic fibrosis.

Grieve AJ, Tluczek A, Racine-Gilles CN, Laxova A, Albers CA, Farrell PM.

J Sch Health. 2011 Nov;81(11):713-20. doi: 10.1111/j.1746-1561.2011.00648.x.

49.

Performance analysis for magnetic resonance imaging with nonlinear encoding fields.

Layton KJ, Morelande M, Farrell PM, Moran B, Johnston LA.

IEEE Trans Med Imaging. 2012 Feb;31(2):391-404. doi: 10.1109/TMI.2011.2169969. Epub 2011 Sep 29.

PMID:
21965195
50.

Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis.

Sanders DB, Li Z, Brody AS, Farrell PM.

Am J Respir Crit Care Med. 2011 Oct 1;184(7):816-21. doi: 10.1164/rccm.201105-0816OC.

Supplemental Content

Loading ...
Support Center